Jie Mei

7PUBLICATIONS
32CO-AUTHORS
Tumour immunologyPredictive and prognostic markersHaematological tumoursHaematologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 09, 2026
Spatiotemporal mapping of tertiary lymphoid structure heterogeneity shapes immune niches and clinical outcomes in intrahepatic cholangiocarcinoma.

|Feb 17, 2025
Assessment of Tumor Burden Score as a Feasible and Reliable Tool for Prognosis Prediction for Hepatocellular Carcinoma Undergoing Hepatectomy: A Multicenter, Retrospective Study.

Renguo Guan, Zehao Zheng, Min Deng

|Apr 10, 2024
Hepatic Arterial Infusion Chemotherapy vs Transcatheter Arterial Chemoembolization as Adjuvant Therapy Following Surgery for MVI-Positive Hepatocellular Carcinoma: A Multicenter Propensity Score Matching Analysis.

Yuhua Wen, Lianghe Lu, Jie Mei

|Dec 16, 2022
Postoperative Adjuvant Hepatic Arterial Infusion Chemotherapy With FOLFOX in Hepatocellular Carcinoma With Microvascular Invasion: A Multicenter, Phase III, Randomized Study.

Shao-Hua Li, Jie Mei, Yuan Cheng

|Apr 26, 2022
Antiviral Treatments Eliminate the Adverse Impacts of High Baseline HBV Loads on the Survival of HBV-Related HCC Patients.

Zili Hu, Xuqi Sun, Jie Mei

|Mar 28, 2022
Transarterial Infusion Chemotherapy with FOLFOX Could be an Effective and Safe Treatment for Unresectable Intrahepatic Cholangiocarcinoma.

Shaohua Li, Min Deng, Qiaoxuan Wang

Pageof 2

Frequent Collaborators

4 joint publications

Rongping Guo

3 joint publications

Renguo Guan

2 joint publications

Min Deng

2 joint publications

Wei Wei